Clinical Research In India: Scope, Opportunities And Challenges

Authors

  • Desai Nilesh V Rajashri Shahu Chhatrapati Institute of Pharmacy, Kolhapur-416002, Maharastra, India
  • Patkar Atul N Rajashri Shahu Chhatrapati Institute of Pharmacy, Kolhapur-416002, Maharastra, India
  • Shinde Shilpa A Rajashri Shahu Chhatrapati Institute of Pharmacy, Kolhapur-416002, Maharastra, India.
  • Kalekar Kamalakar S Rajashri Shahu Chhatrapati Institute of Pharmacy, Kolhapur-416002, Maharastra, India

Keywords:

Clinical research, Bulk drugs, Clinical trials, Pharmaceutical industry

Abstract

Indian pharmaceutical industry is one of the fastest growing sectors of the Indian economy and has made rapid strides over the years. From being import dependent in the 1950s, the industry has achieved self-sufficiency and gained global recognition as a producer of low cost, high quality bulk drugs and formulations. Having proved itself in the international market, India is ready to face the challenges of proving its efficiency as the preferred destination for global clinical trials. A number of factors favour India as a clinical research hub. Firstly, there are numerous government funded medical and pharmaceutical institutions with state of the art facilities, which can serve as ideal centers for multi-centered clinical trials. Secondly, India boasts of well-trained and qualified manpower, well versed in English. More importantly, there is vast clinical material, which can be utilised.

Downloads

Download data is not yet available.

Published

2013-01-01

How to Cite

V, D. N., N, P. A., A, S. S., & S, K. K. (2013). Clinical Research In India: Scope, Opportunities And Challenges. Asian Journal of Pharmaceutical Research and Development, 1(1), 105–108. Retrieved from https://ajprd.com/index.php/journal/article/view/38

Issue

Volume 1st Issue 1st Jan-Feb 2013

Section

Short Communication

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).